Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fixed Dose Combination Tablets”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02077803
What this trial is testing

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 47
Early research (Phase 1)Study completedNCT01211197
What this trial is testing

Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 16
Early research (Phase 1)Study completedNCT01463774
What this trial is testing

Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

Who this might be right for
Healthy
Janssen Research & Development, LLC 74
Large-scale testing (Phase 3)Study completedNCT01815736
What this trial is testing

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

Who this might be right for
HIVHIV Infections
Gilead Sciences 1,443
Early research (Phase 1)Study completedNCT02183636
What this trial is testing

Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin/Pioglitazone Compared With Single Linagliptin and Pioglitazone Tablets Administered Together to Healthy Male and Female Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 39
Early research (Phase 1)Study completedNCT01153711
What this trial is testing

Relative Bioavailability of of Olodaterol and Ketoconazole

Who this might be right for
HealthyPulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 32
Testing effectiveness (Phase 2)Study completedNCT00672412
What this trial is testing

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT01847417
What this trial is testing

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions

Who this might be right for
Ulcers, Duodenal and Gastric
GlaxoSmithKline 24
Early research (Phase 1)Study completedNCT03216278
What this trial is testing

The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions

Who this might be right for
Healthy Subjects in Fasted and Fed State
AstraZeneca 284
Early research (Phase 1)Study completedNCT02223026
What this trial is testing

Relative Bioavailability of a Linagliptin+Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 32
Early research (Phase 1)Study completedNCT03023852
What this trial is testing

Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult Participants

Who this might be right for
Healthy
Janssen-Cilag International NV 45
Not applicableUnknownNCT04398771
What this trial is testing

To Evaluate Safety and Effectiveness of RovatitanTab.

Who this might be right for
HypertensionHyperlipidemias
LG Chem 1,000
Early research (Phase 1)Study completedNCT07182383
What this trial is testing

Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin

Who this might be right for
Healthy Subjects
Daiichi Sankyo 58
Early research (Phase 1)Study completedNCT05083949
What this trial is testing

A Study in Healthy Humans to Assess the Relative Bioavailability of One Fixed-dose Combination Tablet Empagliflozin/Metformin Versus Jardiance® Tablet and Glifage® Tablet Administered Together

Who this might be right for
Healthy
Boehringer Ingelheim 32
Early research (Phase 1)Study completedNCT02259790
What this trial is testing

Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 30
Early research (Phase 1)Study completedNCT02106923
What this trial is testing

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets

Who this might be right for
Healthy
Boehringer Ingelheim 72
Early research (Phase 1)Study completedNCT01218711
What this trial is testing

Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.

Who this might be right for
Healthy
Torrent Pharmaceuticals Limited
Early research (Phase 1)Study completedNCT01246193
What this trial is testing

CKD-828(80/2.5mg) Pharmacokinetic Study

Who this might be right for
Hypertension
Chong Kun Dang Pharmaceutical 65
Early research (Phase 1)Study completedNCT02223065
What this trial is testing

Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 36
Early research (Phase 1)Study completedNCT02060201
What this trial is testing

Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 72
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation